Search

everythinglearnresearchcommunity

for

Search:↓

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Hair follicles may soon be used more for targeted and systemic drug delivery.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Mice hair growth patterns get more complex with age and can change with events like pregnancy or injury.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

New treatments targeting specific genes show promise for treating keratin disorders.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Scientists turned mouse stem cells into skin cells that can grow into skin layers and structures.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

A WNT10A gene mutation leads to ectodermal dysplasia by disrupting cell growth and differentiation.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Inherited ichthyoses cause widespread skin scaling and thickening due to gene mutations.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.